Embargo 16 September 2025 at 17:00 UK time / 12:00 US ET
Peer-reviewed / Human cell lines / Experimental
KIDNEY TRANSPLANT REJECTION ASSOCIATED WITH CHANGES IN LYMPHATIC VESSELS, NEW RESEARCH SHOWS
Scientists have uncovered how lymphatic vessels – the kidney’s ‘plumbing system’ – undergo dramatic changes during chronic transplant rejection, becoming structurally disorganised and spreading to unusual parts of the kidney.
Researchers at the Wellcome Sanger Institute, University College London (UCL) and the University of Cambridge used single-cell sequencing combined with powerful 3D imaging to look at small lymphatic vessels in kidney tissue, comparing healthy kidneys with transplanted kidneys that had been rejected.
Published today (16 September) in the Journal of Clinical Investigation, the research sheds new light on a major unsolved challenge in kidney transplantation and could open the door to new treatments that help transplants last longer.
Kidney transplantation is the most common form of solid organ transplant worldwide. Although the short-term outcomes of kidney transplantation – within a year after surgery – are very good, the long-term outcomes are poorer. Within 10 years, and depending on what country patients are treated in, roughly 50 per cent of kidney grafts will fail.1
Researchers know that a big component of why kidney transplant failure occurs is that the patient's immune system attacks parts of the new kidney – such as the blood vessels within it. However, the role of the lymphatic vessels is far less understood. In healthy kidneys, lymphatic vessels act as the organ’s plumbing system – playing a vital role in draining excess fluid and helping to regulate immune activity. Therefore, the researchers sought to gain a deeper understanding of the lymphatic system during transplant rejection.
The team from the Sanger Institute, UCL and their collaborators used two different and powerful methods — single cell RNA sequencing and advanced 3D imaging. They studied samples from both healthy and transplant rejection patients.2 Single-cell sequencing allows scientists to study the activity of genes in individual cells, one at a time.3 The researchers did this on a very large scale to generate a huge amount of data. Then the team stained large chunks of kidney tissue whilst still intact and used a procedure to make it transparent.4 This 3D imaging helped validate the predictions from the single-cell genetic analysis.5
The researchers found that during kidney transplant rejection, the lymphatic vessels within the transplant change their shape and organisation. The vessels spread into deeper parts of the kidney known as the medulla, which normally has no lymphatic vessels within it. At the same time the cell junctions, which are protein anchors that connect cells, go from looking like loose buttons to tightening up like zippers. This is a change that in other contexts is associated with immune cells getting trapped and unable to escape.
Additionally, the researchers found that the balance of T cells inside and around the vessels was disrupted. These T cells released signals that made the vessels switch on molecules acting like “brakes” for the immune system, in an attempt to calm inflammation. However, this protective response was not enough, as other immune cells and antibodies were seen to be directly attacking the kidney. Strikingly, the vessels themselves were also carrying signs that they too were being targeted by the same harmful antibodies.
These findings challenge the view that lymphatic vessels are simply good or bad in transplant rejection. This study suggests that the lymphatic system is normally protective but impaired in transplant rejection as the findings show the vessels change in ways that could encourage rejection by altering their structure and fuelling immune responses. The results pave the way for research to focus on regenerating or protecting the lymphatic system in chronic kidney rejection.
Dr Daniyal Jafree, first author at the Wellcome Sanger Institute and a clinician-scientist at UCL Great Ormond Street Institute of Child Health, said: “You can think of lymphatic vessels as the kidney’s plumbing system — clearing away excess fluid, immune cells and inflammation. Until now, we have struggled to really understand what these vessels do in kidney transplantation because they are so difficult to study. Using new imaging techniques, we’ve shown that these vessels undergo dramatic changes during rejection and are themselves a target of the immune system.”
Professor David Long, co-senior author, Professor of Paediatric Nephrology at UCL Great Ormond Street Institute of Child Health and Deputy Theme Lead of the NIHR GOSH Biomedical Research Centre, said: “Our innovative methods have allowed us to clearly demonstrate the important role of lymphatic vessels in transplant rejection. By combining single-cell sequencing with advanced 3D imaging, we’ve made a significant step forward in kidney transplant research.”
Professor Menna Clatworthy, co-senior author and Professor of Translational Immunology at the University of Cambridge and the Wellcome Sanger Institute, said: “By uncovering how lymphatic vessels change at both the structural and molecular level, we now have a much clearer picture of the immune environment during transplant rejection. This could help us identify new therapeutic targets to preserve kidney transplants for longer.”
ENDS
Contact details:
Susannah young
Press Office
Wellcome Sanger Institute
Cambridge, CB10 1SA
Email: press.office@sanger.ac.uk
Notes to Editors:
Marcén, R. & Teruel, J. L. (2008) ‘Patient outcomes after kidney allograft loss.’ Transplant Rev (Orlando) DOI: 10.1016/j.trre.2007.09.005.
Human adult kidney tissue was derived from four deceased patients who had opted in for organ donation and undergone multi-organ procurement, but for whom the kidneys had ultimately been declined for implantation by recipient transplant centres. Kidneys were retrieved by UK National Organ Retrieval Services teams. Kidney allograft samples were obtained from three patients at Royal Free London NHS Trust undergoing nephrectomy for graft intolerance syndrome or graft malignancy. All explants were performed by the transplant surgical team. Prior to acquisition, all patients were confirmed negative for COVID-19 by means of a qPCR test.
Single-cell RNA sequencing (RNAseq) can reveal exactly which genes are switched on in each individual cell, revealing cell types and what they do.
Traditionally, kidneys are studied by sending samples to pathology labs where the kidney is cut up very thinly into a cross-section, stained and viewed under a microscope where it is difficult to view in detail.
The 3D imaging equipment was funded by the NIHR Great Ormond Street Hospital Biomedical Research Centre.
Publication:
D. Jafree, B. Stewart, K. Price, et al. (2025) ‘Organ-specific features of human kidney lymphatics are disrupted in chronic transplant rejection.’ Journal of Clinical Investigation. DOI: 10.1172/JCI168962.
Funding:
This research was supported in part by Wellcome and Kidney Research UK. A full list of funders can be found in the publication.
Selected websites:
University of Cambridge
The University of Cambridge is one of the world’s top ten leading universities, with a rich history of radical thinking dating back to 1209. Its mission is to contribute to society through the pursuit of education, learning and research at the highest international levels of excellence.
The University comprises 31 autonomous Colleges and 150 departments, faculties and institutions. Its 24,450 student body includes more than 9,000 international students from 147 countries. In 2020, 70.6% of its new undergraduate students were from state schools and 21.6% from economically disadvantaged areas.
Cambridge research spans almost every discipline, from science, technology, engineering and medicine through to the arts, humanities and social sciences, with multi-disciplinary teams working to address major global challenges. Its researchers provide academic leadership, develop strategic partnerships and collaborate with colleagues worldwide.
The University sits at the heart of the ‘Cambridge cluster’, in which more than 5,300 knowledge-intensive firms employ more than 67,000 people and generate £18 billion in turnover. Cambridge has the highest number of patent applications per 100,000 residents in the UK. www.cam.ac.uk
About UCL – London’s Global University
UCL is a diverse global community of world-class academics, students, industry links, external partners, and alumni. Our powerful collective of individuals and institutions work together to explore new possibilities.
Since 1826, we have championed independent thought by attracting and nurturing the world's best minds. Our community of more than 50,000 students from 150 countries and over 16,000 staff pursues academic excellence, breaks boundaries and makes a positive impact on real world problems.
The Times and Sunday Times University of the Year 2024, we are consistently ranked among the top 10 universities in the world and are one of only a handful of institutions rated as having the strongest academic reputation and the broadest research impact.
We have a progressive and integrated approach to our teaching and research – championing innovation, creativity and cross-disciplinary working. We teach our students how to think, not what to think, and see them as partners, collaborators and contributors.
For almost 200 years, we are proud to have opened higher education to students from a wide range of backgrounds and to change the way we create and share knowledge.
We were the first in England to welcome women to university education and that courageous attitude and disruptive spirit is still alive today. We are UCL.
www.ucl.ac.uk | Follow @uclnews on Bluesky | Read news at www.ucl.ac.uk/news/ | Listen to UCL podcasts on SoundCloud | View images on Flickr | Find out what’s on at UCL Minds
The Wellcome Sanger Institute
The Wellcome Sanger Institute is a world leader in genomics research. We apply and explore genomic technologies at scale to advance understanding of biology and improve health. Making discoveries not easily made elsewhere, our research delivers insights across health, disease, evolution and pathogen biology. We are open and collaborative; our data, results, tools, technologies and training are freely shared across the globe to advance science.
Funded by Wellcome, we have the freedom to think long-term and push the boundaries of genomics. We take on the challenges of applying our research to the real world, where we aim to bring benefit to people and society.
Find out more at www.sanger.ac.uk or follow us on Twitter, Instagram, Facebook, LinkedIn and on our Blog.
About Wellcome
Wellcome supports science to solve the urgent health challenges facing everyone. We support discovery research into life, health and wellbeing, and we’re taking on three worldwide health challenges: mental health, infectious disease and climate and health. https://wellcome.org/
END